openPR Logo
Press release

Lucrative Scenarios Linger over L-Hydroxyphenylalanine Market with Growing Consumer Preference, says Fact.MR Study | Key Players - Fabrichem , Nippon Rika , Formedium , Alphachem , Central Drug House

08-08-2019 10:11 AM CET | Industry, Real Estate & Construction

Press release from: Fact.MR

Lucrative Scenarios Linger over L-Hydroxyphenylalanine

Preference for L-hydroxyphenylalanine as an energy facilitating ingredient in supplements, it being a part of the amino acid family, has remained instrumental in driving the growth of the L-hydroxyphenylalanine market. Moreover prevalence of metabolic disorders and chronic diseases such as Alzheimer’s disease and Parkinson’s disease is expected to create growth opportunities with respect to use of L-hydroxyphenylalanine owing to its efficient adjuvant properties. In addition, studies conducted on L-hydroxyphenylalanine reveal that this aromatic amino acid reflects effective anti-ageing properties that facilitates cell rejuvenation and regulation of melanin content in the skin. Furthermore, potential of L-hydroxyphenylalanine in developing anti-cancer target drugs, by leveraging the link between mitochondrial function and production of melanin in cancerous skin cells, is likely to pave new growth opportunities for the L-hydroxyphenylalanine market in the near future.

Download sample copy of this report: https://www.factmr.com/connectus/sample?flag=S&rep_id=918

A new research study by Fact.MR reveals growth pathways for L-hydroxyphenylalanine from a global viewpoint during the period of forecast, 2018-2028. The report includes estimations that reflect global sales of L-hydroxyphenylalanine which are expected to cross US$ 1,500 Mn by end of the year of assessment (2028). The sales of L-hydroxyphenylalanine are expected to remain concentrated in the developed countries of North America and emerging economies in the Asia Pacific excluding Japan (APEJ) region, given the increasing demand for L-hydroxyphenylalanine in anti-ageing creams and as effective adjuvant in cancer treatment in these regions.

L-Hydroxyphenylalanine Market: Use of L-Hydroxyphenylalanine in Dietary Supplements to Spearhead in the Coming Years

Dietary supplements and nutraceuticals have witnessed significant proliferation across various countries worldwide, given the increasing consumer awareness regarding healthy diet and exercise. Moreover, the growing number of individuals participating in heavy physical activities has further complemented the use of supplements for enhancing muscle growth. Being an amino acid, L-hydroxyphenylalanine as an energy ingredient has witnessed high demand in the production of health supplements, which is expected to fuel the growth of the L-hydroxyphenylalanine market during the period of forecast.

L-Hydroxyphenylalanine Market: High Prevalence of Parkinson’s Disease to Call for Efficient Treatment Solutions

Parkinson’s disease is directly associated with low blood pressure and orthostatic hypotension, that translates into need for effective pharmaceutical formulations that facilitate high energy flow and increase the heart rate. That said, L-hydroxyphenylalanine plays an imperative role in producing significant amount of energy that improves parkinsonian orthostatic hypotension and raises blood pressure, causing the shaking of body to reduce drastically. This factor coupled with increasing cases of Parkinson’s disease across the globe has enhanced the demand of L-hydroxyphenylalanine, in turn contributing to the growth of the L-hydroxyphenylalanine market during the period of forecast.

L-Hydroxyphenylalanine Market: Melanoma Treatment to Create Potential Avenues

Treatment of melanoma is expected to pave significant pathways for growth of the L-hydroxyphenylalanine market, as studies reveal the potential of the L-hydroxyphenylalanine in production of melanin. The Federation of American Societies for Experimental Biology Journal has highlighted the link between mitochondrial function and production of melanin in cancerous skin cells. Post examination revealed that the rate of Reactive Oxygen Species generation in darker cells were high as compared to medium and low level pigments. Provision of L-hydroxyphenylalanine as a building block for melanin production, has been used to activate medium and light cells to increase the production of melanin. This concept is expected to trigger coupling cellular adaptation and stress signaling through ROS signaling, which in turn has the potential to support development of anti-cancer drugs for treating melanoma. This approach is expected provide substantial growth opportunities for the use L-hydroxyphenylalanine, consequently fuelling the growth of the L-hydroxyphenylalanine market during the forecast period.

Inquire about this Report @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=918

Contact Us            
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - https://mypeopletimes.com/

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lucrative Scenarios Linger over L-Hydroxyphenylalanine Market with Growing Consumer Preference, says Fact.MR Study | Key Players - Fabrichem , Nippon Rika , Formedium , Alphachem , Central Drug House here

News-ID: 1819802 • Views: 156

More Releases from Fact.MR

03-20-2020 | Health & Medicine
Fact.MR
Medical Marker Bands Market Grows on the back of Their Radiopacity and Cost-effe …
Radiopacity of medical marker bands is giving significant impetus to their demand in the medical marker bands market. The properties of medical marker bands that increases their visibility under fluoroscopes or x-ray during critical procedures is giving an uptick to their sales worldwide. Manufacturers of medical marker bands are also showing a marked preference for cost-effective materials such as polymer and tantalum instead of traditional gold, platinum and palladium. On
Plastic Tray Market Showcases Future Status of Prime Manufacturers Across Major …
The new report on the global plastic tray market gives estimations of the size of the international market and the overall size and share of key regional segments during the historical assessment period of 2013 - 2017. The overall outlook for the Plastic Tray Market is likely to remain sluggish, with the plastic tray market expected to reach CAGR of 3.6% in terms of revenue during 2018-2027. The business knowledge
MRI-guided Radiation Therapy Systems Market Leading Manufacturers Expected to Mo …
With a multi-disciplinary approach, Fact.MR elaborates an extensive analysis of the historical, current and future outlook of the global MRI-guided radiation therapy systems market as well as the factors responsible for such a growth. Our highly dedicated professionals have provided critical and accurate insights associated with every industry, and region by doing thorough primary and secondary research. Access Research Methodology Prepared By Experts - https://www.factmr.com/connectus/sample?flag=RM&rep_id=2572 We leverage space-age industrial and digitalization tools
Marine Seats Market Growing Demand to Impact Revenue Share during 2018 2028
The new report on the marine seats market provides estimations of the size of the global market and share and size of key regional markets during the historical period of 2013 - 2017. According to the report, the marine seats market is projected to grow at 4.6% CAGR through 2028. The business intelligence study offers readers a granular assessment of key growth dynamics, promising avenues, and the competitive landscape of

All 5 Releases


More Releases for Parkinson’s

Parkinson’s Disease Therapeutic Market- Trends, Outlook 2025
Parkinson’s disease (PD) is a chronic disorder characterized by the malfunctioning and death of vital nerve cells in the brain, and can be characterized by tremor, dementia, and depression. Parkinson’s disease progression leads to uncontrolled body movement of the patient. There is no cure presently for parkinson’s disease only treatments options such as medication and surgery to manage the symptoms are available. Parkinson’s disease mainly affects people over 50 and
Parkinson’s disease Therapeutics Parkinson’s disease Therapeutics Market to …
This report studies the global Parkinson's Disease Therapeutics market, analyzes and researches the Parkinson's Disease Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like GSK Novartis Boehringer Ingelheim Teva Pharmaceutical Abbvie ….. Ask for sample copy @ https://www.researchtrades.com/request-sample/1199125 Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Parkinson's Disease Therapeutics can be split into Medications Therapeutics Medical Devices Therapeutics Buy
US Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in the United States in recent years and it most likely to continue rising in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. The society pays a significant amount towards treating this disease in the country. It is estimated that the total cost to the nation exceeds
Europe Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been estimated that currently, more than 1 million in Europe are affected by Parkinson’s disease. This figure is most likely to double by 2030. Among the most common neurodegenerative disease (after Alzheimer’s disease), Parkinson’s is the second most common and it is expected that
Parkinson’s Disease - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Parkinson’s Disease - Heat Map and Analysis to its growing collection of premium market research reports. Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment. PD is an age-related disorder; symptoms typically begin to first appear in patients in their mid-sixties,
New Education Options for Parkinson’s Caregivers
(4/30/2012- Gilbert, Ariz.) When a loved one is diagnosed with Parkinson’s Disease (PD), it becomes clear that Parkinson’s is a life- changing experience for the entire family — particularly for the primary care provider, who is most often a spouse, child or parent. Family caregivers may not think of themselves as a care providers or recognize their new caregiving tasks. As family members begin helping with doctor visits, taking over financial